West Pharmaceutical Services Goodwill and Intangible Assets 2010-2024 | WST

West Pharmaceutical Services goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • West Pharmaceutical Services goodwill and intangible assets for the quarter ending September 30, 2024 were $0.121B, a 1.14% decline year-over-year.
  • West Pharmaceutical Services goodwill and intangible assets for 2023 were $0.124B, a 1.67% decline from 2022.
  • West Pharmaceutical Services goodwill and intangible assets for 2022 were $0.126B, a 5.42% decline from 2021.
  • West Pharmaceutical Services goodwill and intangible assets for 2021 were $0.133B, a 6.14% decline from 2020.
West Pharmaceutical Services Annual Goodwill and Intangible Assets
(Millions of US $)
2023 $124
2022 $126
2021 $133
2020 $142
2019 $138
2018 $126
2017 $129
2016 $126
2015 $142
2014 $151
2013 $163
2012 $163
2011 $164
2010 $168
2009 $170
West Pharmaceutical Services Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-09-30 $121
2024-06-30 $120
2024-03-31 $122
2023-12-31 $124
2023-09-30 $123
2023-06-30 $125
2023-03-31 $126
2022-12-31 $126
2022-09-30 $122
2022-06-30 $127
2022-03-31 $131
2021-12-31 $133
2021-09-30 $135
2021-06-30 $138
2021-03-31 $138
2020-12-31 $142
2020-09-30 $140
2020-06-30 $139
2020-03-31 $135
2019-12-31 $138
2019-09-30 $135
2019-06-30 $138
2019-03-31 $125
2018-12-31 $126
2018-09-30 $127
2018-06-30 $128
2018-03-31 $132
2017-12-31 $129
2017-09-30 $130
2017-06-30 $129
2017-03-31 $127
2016-12-31 $126
2016-09-30 $130
2016-06-30 $130
2016-03-31 $132
2015-12-31 $142
2015-09-30 $144
2015-06-30 $145
2015-03-31 $145
2014-12-31 $151
2014-09-30 $154
2014-06-30 $160
2014-03-31 $161
2013-12-31 $163
2013-09-30 $162
2013-06-30 $161
2013-03-31 $161
2012-12-31 $163
2012-09-30 $162
2012-06-30 $160
2012-03-31 $164
2011-12-31 $164
2011-09-30 $166
2011-06-30 $170
2011-03-31 $170
2010-12-31 $168
2010-09-30 $170
2010-06-30 $160
2010-03-31 $166
2009-12-31 $170
2009-09-30 $172
2009-06-30 $154
2009-03-31 $152
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49